FACTORS INFLUENCING THE CLINICAL USE OF CHELATES IN IRON STORAGE DISEASE.
D002118:Calcium; D002614:Chelating Agents; D002701:Chloramphenicol; D004358:Drug Therapy; D004492:Edetic Acid; D006801:Humans; D007501:Iron / Q000378:metabolism*; D008228:Lymphoma, Non-Hodgkin; D008274:Magnesium; D004369:Pentetic Acid; D012595:Scleroderma, Systemic; D012806:Siderosis; D013156:Splenectomy; D013789:Thalassemia; D014131:Trace Elements; D014556:Urine
D002614:Chelating Agents; D014131:Trace Elements; D002701:Chloramphenicol; D004369:Pentetic Acid; D004492:Edetic Acid; D007501:Iron; D008274:Magnesium; D002118:Calcium
CALCIUM; CHLORAMPHENICOL; DRUG THERAPY; DTPA; EDTA; IRON METABOLISM; LYMPHOSARCOMA; MAGNESIUM; SCLERODERMA; SIDEROSIS; SPLENECTOMY; THALASSEMIA; TRACE ELEMENTS; URINE